Agreement signedPublished 5 Jan 2022
Amneal Pharmaceuticals /
Saol Therapeutics
Amneal Pharmaceuticals agrees to buy Saol Therapeutics
- Price
- $83.5m
- Stage
- Agreement signed
01 / BuyerAmneal Pharmaceuticals
02 / TargetSaol Therapeutics
What happened
Amneal Pharmaceuticals agreed to acquire Saol Therapeutics for approximately $83.5 million, according to a filing dated Jan. 5, 2022.
The source
Everything on this page comes from the source below.
01
Source · Source
Amneal Pharmaceuticals agrees to buy Saol Therapeutics
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Announced
The source this page is built from.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly